Completed PHASE4 INTERVENTIONAL 2-arm NCT00515151

Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride

Skin Disinfection With Octenidine Dihydrochloride for the Prevention of Catheter-Associated Infections - A Double-Blind, Randomized, Controlled Trial

Sponsor: University Hospital Freiburg

Conditions Bacteremia Bacterial Infections Catheter-Associated Infections Catheterization, Central Venous

Interventions 0.1% Octenidine with 30% 1-propanol and 45% 2-propanol 74% Ethanol with 10% 2-propanol

Updated 5 times since 2017 Last updated: Aug 10, 2007 Started: May 31, 2002 Completion: Apr 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Bacteremia and Bacterial Infections and is currently completed. University Hospital Freiburg leads this study, which shows 5 recorded versions since 2002 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

May 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Freiburg
University Hospital, Basel, Switzerland

Data source: University Hospital Freiburg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland
• Freiburg im Breisgau, Germany